For the treatment of active psoriatic arthritis, I would use an IL17 inhibitor over a TNF inhibitor. Recent evidence supports this approach, and I review these data in the paragraphs below. Two studies of IL-17 inhibitors have now shown equivalent efficacy to TNF inhibitors for the psoriatic musculo...